Evaluation of Drug Candidates for Preclinical Development: Pharmacokinetics, Metabolism, Pharmaceutics, and Toxicology (Wiley Series in Drug Discovery and Development)

Chao Han, PhD, is Associate Director of Pharmacokinetics, Modeling and Simulation, Clinical Pharmacology Sciences, Centocor RD. He has been working in drug discovery and early development for more than ten years, published over thirty research articles in peer-reviewed journals, and written three book chapters. Charles B. Davis, PhD, heads Drug Metabolism and Pharmacokinetics for the Cancer Metabolism Drug Discovery Unit within Cancer Research at GlaxoSmithKline. He has more than twenty years experience in preclinical and clinical development and has served on the leadership teams of three of GSK's Centers of Excellence in Drug Discovery. Binghe Wang, PhD, is Professor and Georgia Research Alliance Eminent Scholar in Drug Discovery in the Department of Chemistry, Georgia State University and Georgia Cancer Coalition Distinguished Scientist. He also serves as editor in chief of Medicinal Research Reviews and is lead editor of Drug Delivery: Principles and Applications (Wiley).Han, Chao is the author of 'Evaluation of Drug Candidates for Preclinical Development: Pharmacokinetics, Metabolism, Pharmaceutics, and Toxicology (Wiley Series in Drug Discovery and Development)', published 2010 under ISBN 9780470044919 and ISBN 0470044918.